NRX Pharmaceuticals, Inc.
NRXP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001719406
No open-market purchases or sales by NRX Pharmaceuticals, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $47.6M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding NRX Pharmaceuticals, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 18 | 25 | +7 |
| Shares | 714.3K | 1.05M | +334.3K (+46.8%) |
| Value | $1.21M | $2.31M | +$1.10M (+91.1%) |
New holders (10)
Institutions that held NRX Pharmaceuticals, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 82,152 | $180.7K | 0.00% |
| Millennium Management LLC | 27,624 | $60.8K | 0.00% |
| Squarepoint Ops LLC | 25,299 | $55.7K | 0.00% |
| Sassicaia Capital Advisers LLC | 15,000 | $33.0K | 0.80% |
| Simplex Trading, LLC | 1,001 | $2.00K | 0.00% |
| Citigroup Inc | 593 | $1.30K | 0.00% |
| FMR LLC | 150 | $330 | 0.00% |
| Group One Trading, L.P. | 99 | $218 | 0.00% |
| Advisor Group Holdings, Inc. | 90 | $198 | 0.00% |
| Carolina Wealth Advisors, LLC | 50 | $110 | 0.00% |
Sold out (3)
Institutions that held NRX Pharmaceuticals, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Sabby Management, LLC | 35,049 | $59.2K |
| Tower Research Capital LLC (TRC) | 2,544 | $4.30K |
| Harbour Investments, Inc. | 47 | $79 |